Olivia Adendorff, P.C.

Since joining Kirkland, Olivia has been involved in the following matters:

• Counsel for Fitbit, assisting in successfully securing clearance from global antitrust regulators for Google’s acquisition of Fitbit
• Represented public company offering health-related online services in FTC consumer protection investigation
• Defended Young Living against multiple putative class action lawsuits alleging false advertising, RICO and fraudulent business practices
• Represented online personal finance company in FTC consumer protection investigation relating to marketing of financial products
• Represented public real estate services company in FTC consumer protection investigation
• Defended global health and personal services company in COPPA-related FTC investigation
• Represented Allergan in False Claims Act litigation alleging anticompetitive conduct in connection with blockbuster Alzheimer’s drugs Namenda and Namzaric
• Counsel for Forest Labs in class action antitrust litigation related to its Androgel products
  

Prior to joining Kirkland, Olivia was involved in the following matters:

• Represented Facebook in the FTC consumer protection and privacy investigation arising from the Cambridge Analytica events widely covered in the news, securing settlement through a revised Consent Decree  
• Served as a member of the litigation team that successfully defended AT&T’s $85 billion acquisition of Time Warner Inc. against a high-profile challenge by the Department of Justice
• Defended Sanofi-Aventis in antitrust-related False Claims Act litigation regarding Sanofi’s Lovenox product, securing complete dismissal of the claims
• Counsel for Tenet Healthcare in multi-billion dollar antitrust class action, obtaining successful settlement of all claims days before trial
• Defended Kimberly-Clark in a Lanham Act false advertising action brought by a competitor in the Northern District of Georgia
• Secured dismissal of historic Title VII class action claims against a major U.S. retailer in California and spin-off regional class actions in four other states
• Represented Allergan in competitor antitrust litigation involving sham litigation, “product switching”, Walker Process, and Sherman Act Section 1 and 2 claims, leading to successful settlement on the eve of summary judgment
• Defeated indirect purchaser antitrust class action claims against Cal-Maine Foods in highly complex federal multi-district litigation antitrust class action
• Counsel for 3M in federal antitrust and patent lawsuits asserting antitrust claims related to 3M’s standard-setting activities, obtaining successful settlement of all claims on the eve of summary judgment
• Successfully defended Mary Kay in class action litigation in California involving allegations of common law fraud and consumer protection violations, securing voluntary dismissal of all claims by the plaintiff

Partner, Gibson Dunn & Crutcher LLP